
Please try another search
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company’s proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer, as an alternative to bacillus calmette–guérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
David Michael Johnson | 57 | 2021 | Independent Chairman of the Board |
Elisabet de los Pinos | 49 | 2007 | Founder, CEO, President & Director |
Karan S. Takhar | 33 | 2021 | Independent Director |
John T. Schiller | - | 2021 | Member of Scientific Advisory Board |
Isaac Yi Kim | - | 2021 | Member of Scientific Advisory Board |
Seth P. Lerner | - | 2021 | Member of Scientific Advisory Board |
Neal D. Shore | - | 2023 | Member of Scientific Advisory Board |
Andrea Apolo | - | 2021 | Member of Scientific Advisory Board |
Max Kates | - | 2023 | Member of Scientific Advisory Board |
Gary Steinberg | - | 2024 | Member of Scientific Advisory Board |
Teresa Bitetti | 63 | 2025 | Director |
Sapna Srivastava | 54 | 2021 | Independent Director |
Brian Marr | - | - | Scientific & Clinical Advisor |
Richard Carvajal | - | - | Scientific & Clinical Advisor |
Giovanni Mariggi | 39 | 2019 | Independent Director |
Carol L. Shields | - | - | Scientific & Clinical Advisor |
Jay S. Duker | 66 | - | Scientific & Clinical Advisor |
Evangelos S. Gragoudas | - | - | Scientific & Clinical Advisor |
Antony Mattessich | 57 | 2021 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review